I/R, Ischemia/reperfusion
Going off a GLP-1 short for glucagon-like peptide-1 receptor agonist isnt without potential consequences
Works in diabetic rats, but not in diabetic humans
Supplied in sealed laboratory vials, the material is intended for analytical investigation, assay development, and experimental applications in professional research environments where documentation and reproducibility are required
( H ) Intracellular cAMP accumulation in human caSMCs treated with the sAC inhibitor KH7 (25 M, dark gray bars), the tmAC inhibitor Ddox (50 M, white bars), or PBS (light gray bars) for 3 hours followed by a 15-minute treatment with GLP-1(2836), scrambled control, IPE, or forskolin
As more oxytocin is released it positively influences even more release of oxytocin